eif2 beta antibody Search Results


phospho eif2s2 p s2  (Novus Biologicals)
93
Novus Biologicals phospho eif2s2 p s2
In vivo CSNK2 inhibition. ( A ) SARS-CoV-2 viral titer measured in mouse lungs 24 h post-inoculation when treated with vehicle or with compound 2 (30 mg/kg p.o. b.i.d.) (n = 5). ( B ) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). ( C ) <t>EIF2S2</t> (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). **: p = 0.0028 using unpaired t -test with Welch’s correction.
Phospho Eif2s2 P S2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho eif2s2 p s2/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
phospho eif2s2 p s2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
eif2 beta antibody (2f3)  (Bio-Techne corporation)
94
Bio-Techne corporation eif2 beta antibody (2f3)
In vivo CSNK2 inhibition. ( A ) SARS-CoV-2 viral titer measured in mouse lungs 24 h post-inoculation when treated with vehicle or with compound 2 (30 mg/kg p.o. b.i.d.) (n = 5). ( B ) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). ( C ) <t>EIF2S2</t> (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). **: p = 0.0028 using unpaired t -test with Welch’s correction.
Eif2 Beta Antibody (2f3), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eif2 beta antibody (2f3)/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
eif2 beta antibody (2f3) - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
phospho eif2s2 ps2  (Proteintech)
93
Proteintech phospho eif2s2 ps2
Figure 7. (A) Viral titer measured in mouse lungs 24 h post inoculation when treated with vehicle or with compound 53 (10 mg/kg i.p. b.i.d.) (n = 5). (B) Western blot for total <t>EIF2S2</t> expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (C) Western blot for EIF2S2 (phospho-Ser2) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (D) EIF2S2 (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lung. (E) Western blot for total AKT expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (F) Western blot for AKT (phospho-Ser129) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (G) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lung.
Phospho Eif2s2 Ps2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho eif2s2 ps2/product/Proteintech
Average 93 stars, based on 1 article reviews
phospho eif2s2 ps2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
eif2 beta antibody  (Bio-Techne corporation)
90
Bio-Techne corporation eif2 beta antibody
Figure 7. (A) Viral titer measured in mouse lungs 24 h post inoculation when treated with vehicle or with compound 53 (10 mg/kg i.p. b.i.d.) (n = 5). (B) Western blot for total <t>EIF2S2</t> expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (C) Western blot for EIF2S2 (phospho-Ser2) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (D) EIF2S2 (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lung. (E) Western blot for total AKT expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (F) Western blot for AKT (phospho-Ser129) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (G) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lung.
Eif2 Beta Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eif2 beta antibody/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
eif2 beta antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


In vivo CSNK2 inhibition. ( A ) SARS-CoV-2 viral titer measured in mouse lungs 24 h post-inoculation when treated with vehicle or with compound 2 (30 mg/kg p.o. b.i.d.) (n = 5). ( B ) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). ( C ) EIF2S2 (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). **: p = 0.0028 using unpaired t -test with Welch’s correction.

Journal: Molecules

Article Title: Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2

doi: 10.3390/molecules29174158

Figure Lengend Snippet: In vivo CSNK2 inhibition. ( A ) SARS-CoV-2 viral titer measured in mouse lungs 24 h post-inoculation when treated with vehicle or with compound 2 (30 mg/kg p.o. b.i.d.) (n = 5). ( B ) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). ( C ) EIF2S2 (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lungs following treatment with compound 2 (30 mg/kg p.o. b.i.d.) for 3, 6, and 36 h (n = 3). **: p = 0.0028 using unpaired t -test with Welch’s correction.

Article Snippet: Blots were blocked in 5% Milk in 1X TBST (0.1% Tween 20) for 1 h at room temperature, washed with 1X TBST, and incubated with primary antibodies in 5% BSA in 1X TBST for 10 h at room temperature; 1:10,000 phospho-EIF2S2 P-S2 (from Laszlo Gyenis from the David Litchfield group), 1:200 EIF2S2 (Novus Biologicals, H00008894-M09, Centennial, CO, USA), 1:5000 GAPDH (Proteintech, 10494-1-AP, Rosemont, IL, USA).

Techniques: In Vivo, Inhibition

Figure 7. (A) Viral titer measured in mouse lungs 24 h post inoculation when treated with vehicle or with compound 53 (10 mg/kg i.p. b.i.d.) (n = 5). (B) Western blot for total EIF2S2 expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (C) Western blot for EIF2S2 (phospho-Ser2) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (D) EIF2S2 (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lung. (E) Western blot for total AKT expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (F) Western blot for AKT (phospho-Ser129) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (G) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lung.

Journal: Journal of medicinal chemistry

Article Title: More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5- a ]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication.

doi: 10.1021/acs.jmedchem.4c00962

Figure Lengend Snippet: Figure 7. (A) Viral titer measured in mouse lungs 24 h post inoculation when treated with vehicle or with compound 53 (10 mg/kg i.p. b.i.d.) (n = 5). (B) Western blot for total EIF2S2 expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (C) Western blot for EIF2S2 (phospho-Ser2) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (D) EIF2S2 (phospho-Ser2) levels normalized to total EIF2S2 levels in mouse lung. (E) Western blot for total AKT expression in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (F) Western blot for AKT (phospho-Ser129) in mouse lung samples after treatment with vehicle or 53 (10 mg/kg i.p. b.i.d.) (n = 3). (G) AKT (phospho-Ser129) levels normalized to total AKT levels in mouse lung.

Article Snippet: Blots were blocked in 5%Milk in 1X TBST (0.1% Tween 20) for 1 hour at room temperature, washed with 1X TBST, and incubated with primary antibodies in 5% BSA in 1X TBST for 10 hours at room temperature; 1:10,000 phospho-EIF2S2 PS2 (provided by Laszlo Gyenis from the David Litchfield group), 1:200 EIF2S2 (Novus Biologicals, H00008894-M09), 1:5000 GAPDH (Proteintech, 10494-1-AP).

Techniques: Western Blot, Expressing